The agency issued a safety warning after two patients contracted antibiotic-resistant infections and one of the patients died.

The decision may facilitate the agency cracking down more effectively on the unproven interventions these companies sell.

FDA researchers report that multiple active ingredients wind up in users’ bloodstream and recommend toxicology testing to investigate the clinical significance of the findings.

The fast-growing fish can now be raised and sold in the US, although it’s likely to be some time before the product hits the market.

The nasal spray to ease intractable depression appears on the US market after decades without novel antidepressant treatments.

Gottlieb will step down after two years at the helm of the US Food and Drug Administration to spend more time with his family.

The bill for fiscal year 2019 increases allocations for NSF, FDA, and others above 2018 levels.

The agency sends warning letters to makers of products that claim to prevent or treat Alzheimer’s and other diseases, and announces changes to its enforcement practices.

From missing paychecks to delayed grants to canceled travel, federal research is feeling the sting.